Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Osteoporosis

Free Subscription 15.03.2021 1 J Clin Endocrinol Metab 12 Osteoporos Int 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Clin Endocrinol Metab

1. NG TANG FUI M, Hoermann R, Bracken K, Handelsman DJ, et al
   Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT.
   J Clin Endocrinol Metab. 2021 Mar 8. pii: 6162862. doi: 10.1210.
   PubMed         Abstract available
   
   

   
   Osteoporos Int

2. VIETH R
   Weaker bones and white skin as adaptions to improve anthropological "fitness" for northern environments.
   Osteoporos Int. 2020;31:617-624.
   PubMed         Abstract available
   
   
3. GEIKER NRW, Molgaard C, Iuliano S, Rizzoli R, et al
   Impact of whole dairy matrix on musculoskeletal health and aging-current knowledge and research gaps.
   Osteoporos Int. 2020;31:601-615.
   PubMed         Abstract available
   
   
4. VAN BODEGRAVEN AA, Bravenboer N
   Perspective on skeletal health in inflammatory bowel disease.
   Osteoporos Int. 2020;31:637-646.
   PubMed         Abstract available
   
   
5. LIU Y, Dash A, Krez A, Kim HJ, et al
   Low volumetric bone density is a risk factor for early complications after spine fusion surgery.
   Osteoporos Int. 2020;31:647-654.
   PubMed         Abstract available
   
   
6. MUGNIER B, Daumas A, Doddoli S, Belmeliani S, et al
   Adherence to fracture liaison service programs in patients over 70: the hidden part of the iceberg.
   Osteoporos Int. 2020 Jan 11. pii: 10.1007/s00198-020-05290.
   PubMed         Abstract available
   
   
7. RUIZ-ADAME M, Correa M
   A systematic review of the indirect and social costs studies in fragility fractures.
   Osteoporos Int. 2020 Jan 30. pii: 10.1007/s00198-020-05319.
   PubMed         Abstract available
   
   
8. LAU EMC, Dinavahi R, Woo YC, Wu CH, et al
   Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study.
   Osteoporos Int. 2020 Feb 11. pii: 10.1007/s00198-020-05324.
   PubMed         Abstract available
   
   
9. ALARCON T, Ojeda-Thies C, Saez-Lopez P, Gomez-Campelo P, et al
   Usefulness of a national hip fracture registry to evaluate the profile of patients in whom antiosteoporotic treatment is prescribed following hospital discharge.
   Osteoporos Int. 2020 Feb 20. pii: 10.1007/s00198-020-05341.
   PubMed         Abstract available
   
   
10. HOLLICK RJ, McKee L, Shim J, Ramsay N, et al
    Introducing mobile fracture prevention services with DXA in Northern Scotland: a comparative study of three rural communities.
    Osteoporos Int. 2020 Feb 21. pii: 10.1007/s00198-020-05316.
    PubMed         Abstract available
    
    
11. IMEL EA, Starzyk K, Gliklich R, Weiss RJ, et al
    Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis.
    Osteoporos Int. 2020;31:2413-2424.
    PubMed         Abstract available
    
    
12. ABDALA R, Levi L, Longobardi V, Zanchetta MB, et al
    Severe bone microarchitecture deterioration in a family with hereditary neuropathy: evidence of the key role of the mechanostat.
    Osteoporos Int. 2020;31:2477-2480.
    PubMed         Abstract available
    
    
13. CAMPONOVO C, Aubry-Rozier B, Lamy O, Gonzalez Rodriguez E, et al
    Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review.
    Osteoporos Int. 2020;31:2485-2491.
    PubMed         Abstract available
    
    

    
    PLoS One

14. FUJIHARA N, Fujihara Y, Hamada S, Yoshida M, et al
    Current practice patterns of osteoporosis treatment in cancer patients and effects of therapeutic interventions in a tertiary center.
    PLoS One. 2021;16:e0248188.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: